Please assess the completion status of the following clinical trial:

Trial Title: Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women who wish to sustain their pregnancy~* Women who have tested positive (blood or urine) for pregnancy in the first trimester~* treated with progestogens or any alternative treatment for early bleeding in pregnancy with evidence of an intrauterine pregnancy / unexplained recurrent OR pregnancy loss (with ≥ 2 previous pregnancy losses) with evidence of an intrauterine pregnancy OR having undergone IVF/ ART embryo transfer and taking progestogen for luteal phase support (LPS), with evidence of an intrauterine pregnancy~* Signed informed consent, allowing consent to contact all treating, or diagnosing HCP~* Able and willing to read and comprehend written instructions; comprehend and complete the questionnaires required by the protocol~Exclusion Criteria:~* Serious disease or disease requiring teratogenic treatment (e.g., Lupus Erythematosus, Multiple Sclerosis, cancer)~* Multifetal pregnancy~* More than four (4) previous IVF embryo transfers~* Previous exposure to dydrogesterone in index pregnancy~* Documented substance abuse~* Treatment with hormones which are known to cause malformations~* Participation in an observational study that might, in the recruiting HCP's opinion, influence the assessment for the current study~* Participation in a randomized clinical trial in the last 3 months~* Previous enrollment in the PEARLY study

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 35 Years
- Healthy Volunteers: t

Study Arms:
- Cohort A (Type: None): Early Pregnancy Bleeding/Recurrent Pregnancy loss
- Cohort B (Type: None): IVF/ART

Based on this trial design, predict the completion outcome and termination type (if applicable).